Article
Translating polygenic risk scores for clinical use by estimating the confidence bounds of risk prediction.
Nature communications - 6 Sept 2021
Sun Jiangming, Wang Yunpeng, Folkersen Lasse, Borné Yan, Amlien Inge, Buil Alfonso, Orho-Melander Marju, Børglum Anders D, Hougaard David M, Melander Olle, Engström Gunnar, Werge Thomas, Lage Kasper
Abstract excerpt
A promise of genomics in precision medicine is to provide individualized genetic risk predictions. Polygenic risk scores (PRS), computed by aggregating effects from many genomic variants, have been developed as a useful tool in complex disease research. However, the application of PRS as a tool for predicting an individual's disease susceptibility in a clinical setting is challenging because PRS typically provide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
